S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
It's almost April 15. Here's how to reduce stress and get your taxes done
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
It's almost April 15. Here's how to reduce stress and get your taxes done
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
It's almost April 15. Here's how to reduce stress and get your taxes done
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Israel hails 'success' in blocking Iran's unprecedented attack. Biden now seeks diplomatic response
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
Diplomat tapped as Latvia's new foreign minister as incumbent quits following flights scandal
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
It's almost April 15. Here's how to reduce stress and get your taxes done
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
NASDAQ:HSIC

Henry Schein (HSIC) Stock Price, News & Analysis

$71.01
-0.80 (-1.11%)
(As of 04/12/2024 ET)
Today's Range
$70.21
$71.57
50-Day Range
$71.01
$80.57
52-Week Range
$60.01
$85.39
Volume
989,207 shs
Average Volume
974,382 shs
Market Capitalization
$9.12 billion
P/E Ratio
22.54
Dividend Yield
N/A
Price Target
$81.09

Henry Schein MarketRank™ Stock Analysis

Analyst Rating
Hold
2.36 Rating Score
Upside/​Downside
14.2% Upside
$81.09 Price Target
Short Interest
Healthy
4.34% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.42
Upright™ Environmental Score
News Sentiment
0.79mentions of Henry Schein in the last 14 days
Based on 10 Articles This Week
Insider Trading
Selling Shares
$693,814 Sold Last Quarter
Proj. Earnings Growth
9.86%
From $5.07 to $5.57 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.67 out of 5 stars

Medical Sector

74th out of 923 stocks

Medical & Hospital Equipment Industry

1st out of 3 stocks

HSIC stock logo

About Henry Schein Stock (NASDAQ:HSIC)

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

HSIC Stock Price History

HSIC Stock News Headlines

Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Henry Schein Presents THRIVELIVE 2024
Henry Schein (HSIC) Faced a Cyber Attack in Q4
20 States with the Most Fluoridated Water in the US
Henry Schein exec sells $216k in company stock
HSIC Apr 2024 45.000 put
HSIC Apr 2024 75.000 call
5 Analysts Assess Henry Schein: What You Need To Know
See More Headlines
Receive HSIC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Henry Schein and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
4/14/2024
Next Earnings (Confirmed)
5/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical & hospital equipment
Sub-Industry
Health Care Distributors
Current Symbol
NASDAQ:HSIC
CUSIP
80640710
Employees
25,000
Year Founded
1932

Price Target and Rating

Average Stock Price Target
$81.09
High Stock Price Target
$96.00
Low Stock Price Target
$65.00
Potential Upside/Downside
+14.2%
Consensus Rating
Hold
Rating Score (0-4)
2.36
Research Coverage
11 Analysts

Profitability

Net Income
$416 million
Pretax Margin
4.39%

Debt

Sales & Book Value

Annual Sales
$12.34 billion
Cash Flow
$6.61 per share
Book Value
$33.01 per share

Miscellaneous

Free Float
127,041,000
Market Cap
$9.12 billion
Optionable
Optionable
Beta
0.87

Social Links

5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

HSIC Stock Analysis - Frequently Asked Questions

Should I buy or sell Henry Schein stock right now?

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings
or view top-rated stocks.

What is Henry Schein's stock price target for 2024?

11 brokerages have issued 1-year target prices for Henry Schein's stock. Their HSIC share price targets range from $65.00 to $96.00. On average, they anticipate the company's stock price to reach $81.09 in the next twelve months. This suggests a possible upside of 14.2% from the stock's current price.
View analysts price targets for HSIC
or view top-rated stocks among Wall Street analysts.

How have HSIC shares performed in 2024?

Henry Schein's stock was trading at $75.71 at the start of the year. Since then, HSIC shares have decreased by 6.2% and is now trading at $71.01.
View the best growth stocks for 2024 here
.

Are investors shorting Henry Schein?

Henry Schein saw a decrease in short interest in the month of March. As of March 31st, there was short interest totaling 5,500,000 shares, a decrease of 6.8% from the March 15th total of 5,900,000 shares. Based on an average daily volume of 1,140,000 shares, the short-interest ratio is currently 4.8 days. Approximately 4.3% of the shares of the company are sold short.
View Henry Schein's Short Interest
.

When is Henry Schein's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 7th 2024.
View our HSIC earnings forecast
.

How can I listen to Henry Schein's earnings call?

Henry Schein will be holding an earnings conference call on Tuesday, May 7th at 10:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Henry Schein's earnings last quarter?

Henry Schein, Inc. (NASDAQ:HSIC) announced its quarterly earnings results on Tuesday, February, 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.70 by $0.04. The firm had revenue of $3.02 billion for the quarter, compared to the consensus estimate of $3 billion. Henry Schein had a net margin of 3.37% and a trailing twelve-month return on equity of 14.03%. The business's quarterly revenue was down 10.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.21 earnings per share.
Read the conference call transcript
.

When did Henry Schein's stock split?

Shares of Henry Schein split on the morning of Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly minted shares were distributed to shareholders after the closing bell on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

How will Henry Schein's stock buyback program work?

Henry Schein announced that its Board of Directors has approved a share buyback program on Thursday, August 18th 2022, which authorizes the company to repurchase $400,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 4% of its shares through open market purchases. Shares repurchase programs are usually an indication that the company's board believes its shares are undervalued.

What guidance has Henry Schein issued on next quarter's earnings?

Henry Schein updated its FY24 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of $5.00 to $5.16 for the period, compared to the consensus estimate of $5.10. The company issued revenue guidance of +8 to +12% yr/yr or $13.326 billion to $13.820 billion, compared to the consensus revenue estimate of $12.93 billion.

What is Stanley M. Bergman's approval rating as Henry Schein's CEO?

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Henry Schein own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Who are Henry Schein's major shareholders?

Henry Schein's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Perpetual Ltd (1.88%), Bridge Creek Capital Management LLC (0.03%), Salem Investment Counselors Inc. (0.03%), Global Assets Advisory LLC (0.01%), Radnor Capital Management LLC (0.01%) and Pensionfund Sabic (0.01%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Gerald A Benjamin, James P Breslawski, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman, Steven Paladino and Walter Siegel.
View institutional ownership trends
.

How do I buy shares of Henry Schein?

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Henry Schein have any subsidiaries?
The following companies are subsidiares of Henry Schein: ACE Surgical Supply Co. Inc., ADS Florida, AUV Veterinary Services, Accord, Alpha Scientific, Arcade Dentaire, Arseus, Arseus Dental Solutions, Arseus Lab, Becker-Parkin Dental Supply, BioHorizons Inc., Butler Schein Animal Health, C&M Vetlink, Camlog USA Inc., DNA Anthos Impianti, Dental Cremer, Dental Trey, Elite Computer Italia, Exan Enterprises Inc., HS Brand Management LLC, HS TM Holdings LLC, HSFR Inc., Handpiece Parts & Repairs Inc., Henry Schein Europe Inc., Henry Schein Global Sourcing Inc., Henry Schein Latin America Pacific Rim Inc., Henry Schein Medical Systems Inc., Henry Schein Practice Solutions Inc., InSource Inc., Jorgen Kruuse, Lincoln Dental Supply, Logiciel Julie, Maddox Practice Group, Maravet, Marrodent, Medivet, Medka, Minerva Dental Limited, Modern Laboratory Services, NLS Animal Health, Noviko, Ortho Organizers, Ortho Technology, Prism Medical Products L.L.C., Prism Medical Products LLC, Project Helium Holdings LLC, Project Spartan Holdings Corp., RxWorks, SG Healthcare Corp., Sirona Direct, SmartPak Equine LLC, Software of Excellence, Sogim Grimouille, Southern Anesthesia & Surgical, S & S Discount Inc., TDSC Inc., The Exan Group, Veterinary Instrumentation, Vetstreet, W. & J. Dunlop, eAssist Inc., and scil animal care.
Read More
This page (NASDAQ:HSIC) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners